I am a
Home I AM A Search Login

Papers of the Week

2020 Aug 21

Farm Hosp



Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison.


Briceño-Casado M D P, Gil-Sierra M D, Fénix-Caballero S
Farm Hosp. 2020 Aug 21; 44(5):212-217.
PMID: 32853126.


New monoclonal antibodies against the calcitonin generelated peptide pathway have recently been developed for the  prevention of migraine. The aim of this study is to compare the efficacy  of monoclonal antibodies against the calcitonin generelated peptide  pathway drugs in chronic migraine through an adjusted indirect  treatment comparison, and to establish whether they can be considered  equivalent therapeutic alternatives in this pathology.